NCT06901362Completed
Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
This study is a cross-sectional study. The study aims to determine the levels of immunity against hepatitis B virus and varicella-zoster virus in medical students.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 401 (actual)
- First submitted
- 22 Mar 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Thammasat University
- Diseases
- Hepatitis B
- NCT number
- NCT06901362
What you commit to
- Study type: Observational
- Participants enrolled: 401
- From 1 Apr 2025 to the primary completion date, 31 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known cases of hepatitis B virus infection
- Known cases of varicella-zoster virus infection
Who the study is looking for
- Medical students
- Age 18 years or older
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Narongkorn Saiphoklang Coordinator of this site? Confirm its status | Pathum Thani | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.